- Home
- SNES vs BNGO Comparison
SNES vs BNGO Comparison
Compare SNES & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- BNGO
- Stock Information
- Founded
- SNES 2004
- BNGO 2003
- Country
- SNES United States
- BNGO United States
- Employees
- SNES N/A
- BNGO N/A
- Industry
- SNES Agricultural Chemicals
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- SNES Industrials
- BNGO Industrials
- Exchange
- SNES Nasdaq
- BNGO Nasdaq
- Market Cap
- SNES 24.0M
- BNGO 24.3M
- IPO Year
- SNES 2016
- BNGO 2018
- Fundamental
- Price
- SNES $3.77
- BNGO $1.93
- Analyst Decision
- SNES Strong Buy
- BNGO Buy
- Analyst Count
- SNES 1
- BNGO 4
- Target Price
- SNES $10.00
- BNGO $7.67
- AVG Volume (30 Days)
- SNES 103.7K
- BNGO 561.0K
- Earning Date
- SNES 11-11-2025
- BNGO 11-12-2025
- Dividend Yield
- SNES N/A
- BNGO N/A
- EPS Growth
- SNES N/A
- BNGO N/A
- EPS
- SNES N/A
- BNGO N/A
- Revenue
- SNES $2,093,000.00
- BNGO $27,426,000.00
- Revenue This Year
- SNES $49.17
- BNGO N/A
- Revenue Next Year
- SNES $89.89
- BNGO $24.54
- P/E Ratio
- SNES N/A
- BNGO N/A
- Revenue Growth
- SNES 36.89
- BNGO N/A
- 52 Week Low
- SNES $1.30
- BNGO $1.50
- 52 Week High
- SNES $6.24
- BNGO $22.80
- Technical
- Relative Strength Index (RSI)
- SNES 42.31
- BNGO 42.05
- Support Level
- SNES $3.60
- BNGO $1.85
- Resistance Level
- SNES $3.90
- BNGO $2.02
- Average True Range (ATR)
- SNES 0.27
- BNGO 0.11
- MACD
- SNES -0.02
- BNGO 0.05
- Stochastic Oscillator
- SNES 20.48
- BNGO 27.87
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.